For breast cancer, our study highlights that markers extending beyond ER, PR, and HER2—including GATA3, Ki-67, E-cadherin, GCDFP-15, cytokeratin (CK), and mammaglobin—are associated with breast epithelial origin and are commonly utilized as key components of diagnostic panels (14, 30). This evidence concerns the gene CDH1 and breast carcinoma.